Cellectar Biosciences (CLRB) has released an update.
The Company has fully exercised its Tranche A warrants from the September 2023 financing, resulting in gross proceeds of about $44.1 million as announced on January 25, 2024.
For further insights into CLRB stock, check out TipRanks’ Stock Analysis page.
